believeyear review year review content believe believe believe believe believe discovery business possible end people sustainable purpose science innovation work gilead community impact practice environment appendix report science drive people difference provide access smart small footprint gilead medicine message chairman groundbreake research welcome celebrate sustainability climate governance ceo daniel development diverse perspective give change environment community global health gri content index look partnership global workforce work year review year review report standardize datum collection measurement reporting activity use industryleade framework united nations global compact ungc united nations sustainable development goal un sdgs global reporting initiative gri carbon disclosure project cdp framework gileads year review organized accordance core reporting framework define gri standard report cover topic list gri content index entity list company sec filing httpinvestorsgileadcomfinancialinformationsecfiling website report content period boundary follow gris principle define report content gilead consider stakeholder inclusiveness sustainability context materiality completeness reporting principle refer gri content index additional information report period boundary indicator include report differ metric base datum availability publication date report indicator report period provide update datum regularly reevaluate reporting boundary material topic ensure current complete year review year review welcome daniel oday chairman chief executive officer daniel oday name chairman ceo follow departure president ceo john f milligan phd end dan appoint follow comprehensive search lead board director select base record success highly scientific competitive therapeutic area deep understanding evolve global healthcare environment unwavere commitment drive innovation serve gilead continue quest transform patient live world year review year review message daniel chairman ceo believe people career ve privilege work smart join colleague remarkable company m humble passionate individual ve see firsthand people achieve opportunity excited potential time give inclusive work environment person voice receive unprecedented change industry company possess resource equal value important ensure people give employee passion longstanding commitment science innovation opportunity learn grow achieve great potential grateful gilead show year company put emphasis diversity inclusion core value essential gilead longterm success new challenge great potential progress gilead wellpositione build legacy deliver transformational medicine believe business sustainable patient dedicate discover develop lifesave medicine large global company understand impact daytoday operation recognize science not solve world tough healthcare people environment help ensure continue execute challenge believe put patient numerous way mission provide lifesave medicine area unmet need build support access healthcare service world forge corporate social responsibility csr program support patient society partnership patient advocacy group healthcare professional planet business gilead establish csr committee help ensure business meet high social environmental standard ve spend lot time thinking gilead unique role leader ability approach csr continued support ungcun sdgs reaffirm shape future healthcare era change seek discover commitment drive short medium longterm action area human develop commercialize innovative therapeutic area unmet medical right labor environment anticorruption need role define core belief chairman ceo commit ensure gilead make believe discovery end unprecedented time industry excite gilead work medication gilead develop decade alongside talented employee harness collective commitment group dedicate individual entire company unite common right patient desire groundbreake discovery help patient save life sense purpose allow gilead difference world thank believe share commitment possible prevention treatment hiv aid fuel quest day lead find cure hiv daniel oday drive pursue cure cancer work field cell therapy lead development cure hepatitis c year review year review look total revenue gilead strive transform promise science technology b therapy power cure prevent treat disease revolutionize standard care believe approach innovation relentlessly pursue good breakthrough science come lab partnership industry leader look year strong consistent operational financial execution portfolio hiv hcv cardiovascular oncology great progress strengthen pipeline product sale largely drive successful launch biktarvy continue uptake descovy genvoya odefsey total revenue hiv medicine increase billion billion previous year overall product sale decrease com pare notably unique dynamic curative nature hepatitis c virus hcv product oncology sale grow substantially total million b cash b cash dividend pay sale yescarta chimeric antigen receptor car cell therapy operation stockholder collaboration b c eqa ush iv c lea ns th b share marketable security repurchase gilead enter partnership license merger acquisition equity investment deal significantly enhance research pipeline therapeutic area include hiv inflammation immunotherapy oncology liver disease b research b development debt include collaboration pfizer sangamo therapeutic verily national expense repay cancer institute hookipa gadeta trianni precision bioscience hifibio therapeu tics tango therapeutics scholar rock agenus purpose purpose believe possible foeuatru pruer sptoosrey purpose expect people like live hiv long hear douglas story word learn gilead work treat prevent ultimately end believe nearly year diagnose hiv douglas brooks alive healthy word thank gilead hiv epidemic visit possible patientturnedemployee doug living proof inspiration gileadcomyir discover develop breakthrough hiv treatment purpose work mission gileads mission discover believe relentlessly pursue breakthrough science develop commercialize innovative come lab partnership therapeutic area unmet primary purpose help people lifethreatene disease work build medical need pillar enable develop deliver innovative medicine upporte patient patientsfirst approach demonstrate collaboration patient advocacy organization work discover develop therapy core revolutionize standard care cure disease offer comprehensive support program help meet need patient caregiver value science innovation research partnership university medical research institution global pharmaceutical leader gilead bring forward scientific clinical advancement prevent treat ntegrity cure lifethreatening disease nclusion inclusiveness promote highperforme workplace culture inform diverse set believe background experience point view enable employee embrace eamwork leverage talent diverse perspective foster sense belong possible purpose achieve career potential contribute gilead success ccountability give recognize patient community face challenge access good possible care know passion scientific discovery e xcellence gilead solve challenge partnership community organization approach corporate philanthropy support initiative program improve access care reduce disparity improve education support local community purpose address global challenge united nations global compact ungc call company align operation universally accept principle human right labor environment anticorruption gilead signatory member join industryleade company support united nations sustainable development goal un sdgs stem ungc un sdgs identify impact area improve quality life people align exist sustainability social practice ungc un sdgs well articulate commitment patient local community society planet gilead support sdgs identify key goal deliver great influence positive impact particular gilead mission provide lifesave therapeutic marginalize underserved community align strongly sdg good health wellbee gilead expand business operation strive support global health sustainable development priority sdgs display page sdg icon report highlight area work correspond specific goal additional information alignment work sdgs find gri content index report purpose purpose good health wellbeing industry innovation infrastructure expand access innovative therapeutic improve human health leverage science innovation develop industryleade worldwide aim help end epidemic aid hepatitis therapeutic area unmet medical need combat communicable disease quality education reduce inequality educate train healthcare provider advanced therapy especially form diversity council enhance inclusion lowincome develop region diversity initiative worldwide gender equality responsible consumption production cultivate inclusive diverse workforce celebrate difference use green sustainable chemistry possible produce race age gender sexual orientation gender identity thinking style therapy benefit human health minimize environmental impact clean water sanitation climate action protect waterdependent ecosystem natural bioswale commit reduce greenhouse gas emission rainwater capture system water conservation measure compare level believe affordable clean energy partnership goal possible generate purchase renewable energy offset gridsupplie forge internal external partnership improve patient care strengthen health system reduce social energy worldwide facility environmental impact science innovation science innovation believe discovery end sciefnecaet ur ein sntoovraytion science innovation treat cancer fail denise diagnose lymphoma birthday learn different chemotherapy regimen fail treat work bring tumor tell month live hope patient like believe discover car cell therapy enrol patient denise visit discovery cell therapy trial cuttingedge treatment gileadcomyir end engineer immune system attack cancer science innovation science innovation science drive gilead science innovation goal develop lifesave product difference patient world envision world disease treatable curable preventable year scientific expertise develop therapy revolutionize standard care disease recognize science support innovative partnership address challenge certain community disproportionally believe susceptible disease discovery end invest community apply rigor use scientific innovation support sustainable program focus intersection disease like hiv social determinants health portfolio market product target area significant unmet medical need include hivaid liver disease hematology oncology inflammatory disease respiratory disease science innovation science innovation groundbreake research development expand treatment include investigational longacte injectable potentially gilead portfolio feature number category first include complete treatment access china administer month regimen hiv chronic hepatitis c virus hcv infection available oncedaily month long single pill yescarta chimeric antigen receptor car cell therapy compound gs investigational gileads presence china adult patient relapse refractory large bcell lymphoma small molecule capsid inhibitor design expand significantly disrupt protein shell protect china national medicinal product today research development effort include hundred ongoing viral genome interfere stage administration nmpa approve plan clinical study evaluate compound potential viruss replication cycle gs epclusa genvoya vemlidy medicine set new standard care end research harvoni descovy clinical trial look development pipeline include active clinical study drug pair create potentially phase clinical trial increase access safe effective welltolerated longacte effective treatment vital public treatment regimen health world populous country addition develop new treatment new therapy hiv new hiv diagnose option gilead commit prevention estimate million people live hiv infection appropriate individual decade gilead leader develop innovative therapy help hcv use truvada prep pre treat hiv gilead new hiv therapy biktarvy daily single tablet regimen exposure prophylaxis oncedaily tablet combine bictegravir emtricitabine tenofovir alafenamide taf approve gilead employee medication approve help fda february biktarvy find effective tolerable work china prevent hiv infection prep approach adult new treatment stably suppress adult patient transition help individual hivnegative believe medicine united states biktarvy prescribe product risk hiv infection reduce chance discovery month compare product launch treat hiv acquire hiv sex gilead end single tablet regiman help simple patient compare launch television advertisement early hiv treatment require dozen medication take truvada prep help raise awareness day multiple time day scientist continue work develop new encourage people high treatment goal make easy patient adhere provide risk hiv exposure candid additional treatment dose schedule option compound conversation hiv prevention effective patient disease show great resistance healthcare provider science innovation science innovation biktarvy united states biktarvy prescribe product month compare product launch treat hiv worldwide sale b believe discovery end science innovation science innovation kite advance state oncology gilead acquire kite pharma solidify dedication helping achieve ambitious goal st century medicine cure cancer continue advance pipeline cancer therapy include cell therapy immunotherapy target therapy kite cell therapy portfolio lead yescarta axicabtagene ciloleucel chimeric antigen receptor car cell therapy approve fda treatment adult patient relapse refractory large bcell lymphoma line systemic therapy yescarta work genetically modify immune cell target tumor effectively reengineere patient cell detect kill cancer cell european commission grant marketing authorization yescarta august support patient europe kite establish distribution center netherlands building manufacturing facility expect begin operating achievement kite cap prestigious honor approach tackle liver disease biopharmaceutical research yescarta name cowinner prix galien usa award good biotechnology product prix galien aim promote significant advance gilead develop breakthrough medicine cure patient hepatitis c pharmaceutical research year award give credit important drug virus hcv infection regardless virus genotype cirrhosis status gilead introduce public market achievement good research develop vemlidy help people live hepatitis b virus hbv infection team pharmaceutical field consider industry equivalent nobel control condition day small oncedaily tablet prize high accolade pharmaceutical research development believe discovery know care people live chronic illness addition ongoing study yescarta kite advance novel investigational end medicine screen increase patient access treatment critical s therapy range hematologic malignancy solid tumor continue work expand hepatitis screen linkage care advance oncology research partnership license atrisk individual increase access medicine world agreement mas strategic investment found member actively support effort government partner professional foundation national institute healths partnership accelerate cancer organization patient advocacy group payer healthcare professional therapie gilead collaborate peer enhance understanding cancer declare intention commitment work world health immunotherapy engineer cell therapy organization goal elimination viral hepatitis world science innovation science innovation epclusa pangenotypic panfibrotic treatment account advance potential treatment inflammatory disease majority gilead hcv product sale united states hcv sale europe nmpa approve epclusa harvoni despite available effective medication patient rheumatoid treatment hcv vemlidy treatment hbv bring new treatment arthritis ra inflammatory bowel disease ibd inflammatory condition option million people china live viral hepatitis exist treatment stop provide adequate control symptom time believe additional treatment option need aim hbv continue work goal find cure gilead share break efficacy ceiling patient inflammatory condition numerous research finding scientific community enter new strategic partnership supplement inhouse research galapagos gilead enter global collaboration development commercialization filgotinib investigational jak inhibitor develop medicine nonalcoholic steatohepatitis nash inflammatory indication gilead galapago announce primary sclerose cholangitis psc nash disease cause fat accumulation equator phase trial filgotinib psoriatic arthritis meet primary endpoint inflammation liver lead liver fibrosis expect gilead galapago announce phase b selection trial filgotinib lead cause liver transplantation psc rare chronic condition ulcerative colitis progress phase follow interim futility analysis damage bile duct lead cirrhosis liver failure cancer datum monitor committee dmc recommend study proceed treatment cure psc stop disease progression plan evaluate mg mg oncedaily dose biologicexperienced biologicnave patient september gilead galapagos announce gilead advance multiple novel investigational compound treatment tortuga phase trial filgotinib ankylose spondylitis meet primary advanced fibrosis nash currently conduct phase trial psc endpoint time gilead galapago announce phase finch trial ra patient refractory biologic meet primary key secondary endpoint line previous study result equator believe asegua bridge gap treatment tortuga publish lancet discovery filgotinib lead asset therapeutic area potential establish end asegua therapeutic gilead subsidiary produce authorize generics foundation gilead combination treatment strategy improve outcome epclusa harvoni offer health insurer low list price option patient ra ibd inflammatory disease continue develop hcv medication pricing authorize generic closely reflect exist internal compound actively evaluate external opportunity discount brand product provide payer policy contractual complement accelerate internal effort constraint option enable easily provide coverage insure population ultimately offer promise treatment cure patient united states science innovation science innovation research structure research research collaboration acquisition collaboration collaboration immunophenotype tcell buildto buy electroporation modulation latent platform inflam cell therapy tgffor fibrosis research research research outlicense research research research research collaboration collaboration collaboration momelotinibfor collaboration collaboration collaboration collaboration gene edit cell therapie vaccine myeloproliferative gene edit neoantigen tcrs hiv cure bispecific abs io cell therapy target patient hivhbv cure disease hbv cure specific tumor neoantigen believe clinical study clinical study product research research collaboration collaboration acquisition collaboration collaboration discovery yescarta gs hiv product crispr screen novel small utomilumab vaccine japan io molecules end lbcl hiv cure fibrosis dna gnisnecil spihsrentrap stnemtsevni ytiuqe partnership collaboration include strategic collaboration precision bioscience develop therapy target vivo elimination hbv precision proprietary genome editing platform arcus research collaboration license agreement grant gilead exclusive right hookipas therat vaxwave arenavirus vectorbase immunization fast progress possible fight technology hbv hiv scientific collaboration verily life science lifethreatening disease gilead find way build verilys immunoscape platform identify well understand immunologic basis complementary strength accomplishment industry peer rheumatoid arthritis inflammatory bowel disease lupusrelated disease collaboration acquisition important gilead growth strategy gilead plan pursue additional collaboration gilead execute partnership licensing deal complete equity investment biopharma company collaboration provide gilead access new technology resource enable rapid advancement oncology cell strategic collaboration investment therapy hiv liver disease inflammatory disease collaboration oncology cell therapy include follow industry innovator worldwide collaboration sangamos zinc finger nuclease gene editing technology platform develop nextgeneration ex vivo cell therapie new cooperative research development agreement national cancer institute develop adoptive cell therapy target patientspecific tumor neoantigen strategic collaboration gadeta develop novel gamma delta cell receptor therapie research collaboration license agreement hifibio h h h therapeutic develop technology discovery neoantigenreactive cell receptor oncology global strategic collaboration tango therapeutic innovation fund pipeline target immunooncology treatment bioventuresfundworke gilead working gilead believe people woferaktinugr ea ts tgoirleyad work gilead different commit mission katie watson tara maccannell come different hear katie background gilead share vision work tara mean deliver lifechange medicine patient world team believe celebrate difference unique perspective gilead visit employee gilead company great people sum part employee notsosecret strategy gileadcomyir tackle world challenging disease work gilead work gilead gilead offer employee unique opportunity combine professional advance ment continual learning ability impact local community people world challenge great contribution small inspire act people bring spirit service advance scientific research mentorship community engagement proud support workplace culture allow bring good self serve high purpose reward recognize retain employee gilead offer competitive compensation program countryfocuse people benefit relate health wellness retirement disability leave absence total reward program design help attract cultivate retain difference industry talented workforce offer employee financial benefit include base pay bonus stock grant opportunity access variety health wellness resource timeoff benefit support training education assess benefit package year ensure place right offering believe gilead inspire deliver lifesave therapy patient help attract retain critical talent total reward package cover people need core value integrity inclusion teamwork accountability follow core element excellence cornerstone compensation financial benefit commit create promote maintain inclusive highper form culture team member embrace leverage tal gilead payforperformance company commit pay equity pay ent background sense share purpose culture excellence employee base marketbase salary range pay decision enable reach million patient world turn tide seri regard personal characteristic gender race color national origin ous lifethreatening disease ethnicity age disability sexual orientation gender identity gender expression work gilead work gilead genetic information religion veteran status gilead employee receive regular wellness offering include biometric screening wellness seminar onsite performance career development review monitor review employee fitness center annual fitness reimbursement health assessment tool risk compensation annual basis ensure pay practice gender neutral benefit include sick day disability benefit companypaid life accidental death dismemberment business travel accident insurance gilead salary ratio expand health woman man welfare benefit include apply united states behavioral analysis therapy fertility support employee financial benefit include employee assistance program eap service include financial legal retirement saving matching contribution available country preretirement eld care child care consultation clinical counseling base local market practice regulation new online coach tool provide employee family access ondemand behavioral health support employee stock purchase program espp enable eligible gilead employee stockholder purchase gilead stock time discount consistent internal revenue service requirement believe detailed information gilead define benefit plan obligation visit gilead offer competitive timeoff program help employee remain rest company shareholder center website balance year timeoff benefit include companypaid vacation day people holiday vary country country base compliance local law regulation common market practice health welfare benefit offer familyfriendly leave absence parental adoption leave demonstrate commitment health wellbee employee employee country include week pay parental time ppto family offer marketcompetitive wellness extend healthcare risk benefit employee united states country work gilead work gilead worldwide gilead support continued employee employee parental leave return education discount mba work end leave program golden gate southern california university employee male female total participate onsite mba hold week number employee entitle parental leave program foster city number employee take parental leave service number employee return work leave end give number employee retain month return work follow period parental leave gilead annual week service bring number employee take parental leave gilead launch give employee world return work rate program match difference community return work rate donation eligible nonprofit organization october kite team southern retention rate employee year california participate week em rp el fo oy ree e l ln eo mt e pl li og yib el ee f ar r eb cd hin ng ic al le lya eve lig iba ley tr oe q tau ke es p ap er ns l e l ae va ev e absence spend time new child donate california fire service volunteer assemble care foundation wildfire relief fund los package child receive cancer angeles north valley community treatment los angelesarea hospital professional personal development foundation chico california help decorate halloween party boy affect northern southern girl club location contribute g ilead learn development program foster culture continuous california fire food drive westside food bank learning design help employee develop crossfunctional skill tool grow career learn culture employee family week service give chance believe evacuate wildfire work provide little hope people gilead employee complete hour california greece hurricane michael smile people need small professional management leadership development training florida typhoon asia offer gesture positive ripple program average hour employee pay time financial assistance help effect help create bond cover cost hotel room meal local community employee receive reimbursement tuition expense incur damaged personal belonging pursue undergraduate graduate certificate course lindy specialist cell therapy ii accredited college university annual reimbursement maximum eligibility vary country country online course assume hour work gilead work gilead volunteering community gilead legal department spend approximately probono gilead aim positively impact community hour represent client work live connect variety area include domestic talent employee unmet need violence survivor asylum community encourage worldwide immigrant juvenile veteran employee engage volunteer activity seek medical aid benefit core area focus underserved community education environment health awarenessoutreach worldwide hour domestic violence representation employee receive additional pay day work volunteer organization choice hour immigrant representation gilead second annual week service employee world gave believe local community provide meal people maintenance habitat restoration care package member military assistance foster city employee spend hour veteran community service hour support representation follow organization pacifica beach coalition lifemove operation care comfort work gilead work gilead boy girls clubs oakland work demonstrate commitment commitment glide inclusion require larkin street youth service lgbtq encourage employee southern california participate week support community service time volunteer nonprofit organization support recognize mitigate youth family los angeles area unconscious bias honor diversity make consider multiple effective workforce help well pathway success understand serve patient welcome respect people world natural start background experience develop treatment disease disproportionately affect lbgtq celebrate diverse seek diverse perspective community fiercely commit drive innovation support lgbtq employee today perspective advocate transgender right marching pride parade form world host honest conversation gilead expand new therapeutic area geographic region business diversity council inclusion diversity gilead stand increasingly complex building inclusive diverse workforce help lgbtq employee take chair senior evolve business ultimately well serve patient pride difference believe generate great diversity thought accelerate innovation amplify management community productivity achieve mission improve patient care meeting unmet people measure ability medical need world varied perspective experience attract develop help drive innovation gilead diversity gilead mean recognize accept way differ commit promote inclusion retain employee include visible difference age gender ethnicity physical appearance diversity simply right thing underlie difference thinking style religion nationality veteran diverse background daniel chairman ceo status sexual orientation sexual identity education gilead add inclusion core value well help build community accountability work gilead work gilead new diversity council track progress relative follow improvement goal amplify gilead asian interest network gain employee voice gain unite asian employee increase transparency diversity datum ally deepen cultural understanding company listen employee crucial implement tracking diversity action plan specific different organization region continue success especially continue evolve obtain valuable insight gilead leadership organization black building inclusive culture integrating expand employee periodically issue workplace employee globe unconscious bias training globally launch multicultural tool survey cover multitude topic include globe work cultivate improve team effectiveness border leadership people core value impact innovation career african descent advance opportunity people development inclusion engagement work value environment collaboration efficiency create community gilead woman gilead global network woman gilead boost employee participate employee resource group erg recruit develop support female employee group provide opportunity leadership development community involvement worldwide employee thrive future network mentoring skill advancement participate recruitment diverse provide valuable candidate way gilead employee difference lgbtq alliance usual work responsibility feedback help lgbtq alliance keep gilead place shape business gender diversity member chapter world gilead celebrate community prioritize people feel erg help scale inclusion diversity initiative create sense strategy move forward empower belong employee believe gileado receive score human right campaign hrc gileado member embrace espouse appreciation people corporate equality index cei national benchmarking tool corporate policy multifacete latino culture gilead goal practice relate lesbian gay bisexual transgender lgbtq employee enhance recruitment retention diverse talent recognition diversity inclusion effort forbe name gilead gilead veteran engagement good employer diversity team gvet gvet play important role recognize appreciate support veteran active duty military family work gilead work gilead result survey reflect positive feedback category include core value impact innovation career development time employee identify opportunity improve collaboration operational efficiency inclusion diversity initiative response feedback form action team late evaluate opportunity action spirit create community accountability action team meet quarterly report progress respect improvement opportunity improvement opportunity action implement organizational network analysis ona map connection employee collaboration understand improve crossfunctional crosslocational collaboration unveil new work schedule option increase efficiency flexibility employee work form diversity council create inclusion diversity organizational diversity action plan enhance believe diverse hiring development program people work gilead work gilead global workforce united states gender age raceethnicity distribution gilead worldwide staff grow people strive workforce close community tangible result contribution individual matter chance enhance skill ongoing development people number people number gilead continually look opportunity diversify workforce datum important process year review total new hire voluntary turnover gender race ethnicity metric follow snapshot gilead workforce demographic datum gender raceethnicity worldwide new hire voluntary turnover black believe african hispanic eeo category male female white american latino asian people new hire executive new hire rate firstmidlevel manager voluntary turnover professional voluntary turnover rate total gilead population new hire datum include individual hire externally exist employee change position internally include calculation work gilead work gilead building culture workplace safety gilead believe safe secure workplace inspire innovation promote health wellness productivity workplace safety training security program design prevent occupational injury illnesse promote culture reporting safety measure include tailor training session annual refresher course detailed assessment incident nearmisse worldwide frequent workrelate injury musculoskeletal extremity neck strain cause material handle ergonomic slip fall motor vehicle hazard ergonomic trip hazard lead highconsequence injury individual unable recover fully month executive management meet quarterly review environmental safety performance site joint managementline health safety committee review sitelevel performance team complete indepth review individual site incident occur identify cause determine similar event happen future gilead workforce datum believe fte nonfte employee number fatality result workrelate injury people rate fatality result workrelate injury number highconsequence workrelate injury rate highconsequence workrelate injury total number recordable workrelate injury rate recordable workrelate injury rate calculate base hour work fte nonfte eg temporary worker managed directly gilead consistent usosha record keeping requirement datum report authority internally number highconsequence workrelate injury base lose timeday away restrict workday case report osha community impact community impact believe cofmematuunriet ys itmoprayct community impact age hiv manage new challenge year hiv community push boundary break barrier campaign positive change generation people hiv enter later life new unprecedented challenge emerge historic challenge remain launch uk gilead hiv age positively aim address great challenge age hiv take action today learn gilead tomorrow believe hiv age positively visit hiv age positively embrace ethos think thing gileadgivingcouk differently provide innovative idea fresh perspective work future thinker individual know groundbreaking work inside outside hiv space hiv age positively initiative gilead provide funding project inspire think thing differently focus hiv age positively key focused area community action personal health equality health service community impact community impact provide access medicine effective treat prevent cure disease medicine available patient need access medicine program gilead expand access treatment help patient overcome barrier medicine need obstacle care occur resourcerich country develop world alike gilead collaborate government nongovernmental organization healthcare provider payer partner world believe increase access treatment community impact community impact access medicine patient assistance program eligible patient insurance apply patient assistance program receive free treatment directly united states gilead healthcare landscape complex difficult navigate ease burden place patient caregiver gilead patient assistance expand access program program help provide access medicine copay assistance counseling therapeutic area accordance applicable law people lifethreatening condition not eligible clinical trial therapeutic option available meet addition discount program aim address affordability challenge need gilead expand access program offer access investigational patient gilead pursue creative solution challenge instance medicine program vary regionally result unique regulatory mech gilead authorize launch generic version epclusa harvoni anism worldwide investigational medicine receive regulatory united states start january separate subsidiary asegua approval potential risk benefit establish patient therapeutic llc authorize generic allow great access patient physician carefully consider possible benefit risk seek ac cess compassionate use gilead patient support program rapid access medication program patient counseling case manager help patient navigate insurance coverage access treatment assistance include find alternative coverage copay gilead recognize extreme weather event threaten health system support appropriate interrupt access care effort prevent interruption patient treat ment gilead medicine continental united states territory believe assistance individual live hiv gilead work state implement emergency disaster procedure patient support program aid drug assistance program provide low pricing hiv medicine gilead work healthcare provider pharmacy help provide prescribe approximately half individual take gilead hiv medicines united states gilead medication patient need individual eligible obtain receive federal state program substantially discount price day replacement supply gilead medication cost gilead truvada prep medication assistance program help provide access truvada prep eligible individual united states insurance gilead offer copay assistance program help eligible people insurance offset outofpocket cost program provide consistent access prevention treatment indication community impact community impact tiere pricing discount medicine base disease burden national percapita income responsible generic licensing product enable highquality lowcost version hiv viral hepatitis medicine low middleincome country advocacy public health initiative policy maximize patient reach prevent new infection strengthen health system bolster diagnostic treatment surveillance capacity collaborative research target innovative therapy inform drug delivery help country map disease burden information initiative improve global access lifesave medicine public health education refer impact report emerge market access medicine develop world give year gilead carry pioneering program believe partnership provide access medicine low middleincome community country time learn onesizefitsall solution treatment access challenge gilead know solve challenge patient s work public health official community advocate researcher community face access good possible care gilead corporate give doctor patient understand barrier opportunity focus program fund project support underserved community systematically community impact hiv viral hepatitis visceral leishmaniasis apply experience social economic obstacle health build relationship patient variety approach increase disease awareness engage partner strategically advocate nonprofit healthcare professional world work tirelessly deliver medicine efficiently include local community improve people live day day community impact community impact gilead provide million cash donation reduce health disparity eliminate barrier healthcare encounter underserved population advance education healthcare professional support local community tm operate donation support relief effort community recover wildfire california hurricane damage eastern united states flood india outbreak ebola democratic republic congo help communitybased organization reduce hivrelated health gilead compass initiative disparity build awareness advance education reduce stigma south home onethird population see new hiv infection death hiv country state high rate new hiv diagnose south bring compass coordinating center solution hardesthit region gilead launch compass commitment partnership address hivaids southern states initiative december deliver million grant support compass manage coordinating center draw long local organization evidencebase history local engagement effectively understand develop program solution meet need people live meet unique need southern community impact hivaid rollin school public health emory university oversee program capacity building share knowledge believe promote visibility program university houston graduate college social work gcsw oversee program focus wellbee mental health advocate conference traumainforme care region southern aids coalition sac oversee awareness education antistigma campaign host share learn opportunity design foster collaboration good practice connection subjectmatter expert community impact community impact partnership advance education improve cancer care gilead launch lift initiative provide project grant organization focus cell therapy cuttingedge immunotherapy modify patient immune cell target cancer cell lift grantee include american society blood marrow transplantation arm foundation regenerative medicine education research match foundation cancer support community lazarex cancer foundation believe leukemia lymphoma society lymphoma research foundation lift grant project increase awareness education improve experience patient family caregiver increase access clinical trial practice environment practice environment believe business sustainable practfiecaetsu r ee nsvtoirroynment practice environment care environment james oregan mission positively impact community reduce gilead footprint sustainability manager james cork team manufacturing facility cork ireland s keep thing green visit year cork mark sixth consecutive year zerowaste gileadcomyir believe facility run renewable energy business sustainable practice environment practice environment smart green building gilead small footprint building house laboratory develop medicine help million people world live healthy life embrace core sustainability gilead commit socially environmentally responsible green building practice conserve natural resource eliminate unnecessary waste responsibly source material enable well production medicine help people live world deliver highperformance work environment operate efficiently promote illness health productivity employee year develop worldwide sustainability strategy build partner building designer engineers contractor share initiative reduce impact associate supply chain manufactur commitment sustainability add value phase development ing distribution product design construction operation process streamline effort align local green building standard worldwide corporate facility include leadership energy environmental design leed building research establishment environmental assessment method breeam past year gilead real estate portfolio grow million square foot use responsible growth strategy minimize environmental gilead begin take step lee silver certification new site impact improve operational efficiency pursue vision advance frederick maryland breeam certification new site hoofddorp therapie lifethreatening disease worldwide netherland site expand gilead portfolio facility believe international facility master plan valuable resource thoughtfully manag pursuing achieve green building recognition ing infrastructure real estate decision business sustainable gilead transition lowcarbon future mitigate effect climate change line paris agreement central aim keep global temperature rise degree celsius century estab lishe goal reduce global scope greenhouse gas emission compare baseline practice environment practice environment gilead site highlight responsible delivery system foster city california united states start electricity supply worldwide gilead pharmaceutical development manufacturing pdm team responsible headquarters source renewable energy ensure therapy available patient need renewable energy procurement effort foster city cork ireland demonstrate use combination companyowne facility expand network reduction scope emission achieve half ghg reduction goal procurement effort expand foster city international partner manufacture package distribute product edmonton alberta canada iso meet grow demand innovative medicine area unmet need recover highpurity wastewater laboratory cool vacuum pump onsite constantly work optimize diversify manufacturing capability save million liter freshwater year viread tenofovir disoproxil fumarate tdf launch gilead produce stockley park england bottle manufacturing site equivalent year supply stockley park eliminate use plastic water bottle site avoid patient gilead produce million bottle soliddose tablet waste singleuse plastic bottle year capsule pediatric formulation million sterile vial manufacture dozen partner site worldwide drive growth activity newly build facility total energy consumption increase baseline time investment increase manufacture production commit socially procure lowcarbon source energy reduce worldwide scope market environmentally responsible manner gilead supplier active pharmaceutical base greenhouse gas emission gilead actively look opportunity ingredient apis drug product observe good manufacturing practice increase proportion energy derive renewable source gmp regulation require food drug administration fda relevant health authority worldwide gmp cover aspect production environmental performance summary include manufacturing procedure test method maintenance premise unit equipment training personal hygiene staff appropriate documentation believe total area facility worldwide operational control million sq ft maintain high level quality product package distribute business sustainable energy use accordance industry regulation standard regularly assess total energy consumption mwh operation identify opportunity enhance process renewable energy purchase mwh compromise quality greenhouse gas emission scope mt coe end gilead consolidated product shipment site san scope marketbase mt coe dimas la verne california distribution center midwest east coast reduce annual ground freight mileage restatement square footage value report pg year review refer disclosure gri content index additional detail practice environment practice environment gilead begin utilize new distribution site ohio strategic location pharmaceutical environment facility substantially reduce shipping distance product package manufacturing partner site midwest eastern united states provide pharmaceutical environment pie health consequence additional product storage capacity help mitigate potential supplychain people wildlife pharmaceutical typically reach environment disruption risk excretion treat patient improper disposal medication release production facility local water source gilead manufacture facility maintain high operational standard release well yield green chemistry active pharmaceutical ingredient environment adhere strong internal policy operate compliance regulatory requirement wastewater discharge gilead use green sustainable chemistry practice reduce environmental solid waste disposal impact manufacturing process process chemist develop implement new green chemistry protocol innovative use enzymatic gilead member pharmaceutical product stewardship work group ppswg catalysis flow chemistry use greener solvent api synthesis green membership association drug manufacturer form address complex issue chemistry practice allow associate disposal unused unwanted pharmaceutical product ppswg provide member platform organize present sciencebase datum improve potency apis significantly reduce chemical waste safe pharmaceutical disposal practice coordinate industry effort raise production biktarvy single tablet regimen launch treatment awareness appropriate disposal method ppswg help manufacturer hiv understand comply enact drug takeback stewardship law ordinance nationwide significantly reduce process mass intensity pmi investigational compound currently development ppswg gilead support consumerfocuse drug takeback stewardship believe effort medproject perform medication education disposal work pmi green chemistry metric quantify efficiency process pmi jurisdiction country gilead contribute support med business represent mass process input substrate reagent solvent sustainable project takeback effort december medproject service approximately water divide mass isolate product pmi entire api active medication disposal kiosk collect metric ton process route analyze evaluate contribution input category unwanted medication medproject receive unwanted medical mailer substrate reagent solvent water analysis identify opportunity distribution program california washington hold inperson drug takeback improve api manufacturing process event san francisco alameda county california collect metric ton unwanted medication practice environment practice environment gilead join american use child labor unfair treatment wage benefit work hour improve drug potency chemical society green chemistry force labor human trafficking discrimination base race color gender green chemistry institute pharmaceutical roundtable religion disability sexual orientation gender identity expression support technique reduce acs gcipr member gilead compliance applicable legislation include united kingdom modern chemical waste associate involve development antislavery act api manufacturing tool educational resource biktarvy patient facilitate global collaboration responsible source program year compare stribild influence pharmaceutical industry gilead previous generation research agenda gileads responsible source program build relationship supplier meet hiv fixeddose combination criterion inclusion diversity health safety human labor right anti tablet contain corruption environmental performance supplier management consideration work drug substance supplier single mg tablet biktarvy pillar responsible source api potency mg share tablet stribild eliminate gilead supplier align core value meet financial performance kilogram chemical production value criterion order qualified business gilead waste patient year ensure consistently gilead hiv single tablet regimen provide high quality therapy partner supplier share annual chemical waste produce believe similar principle responsible kgpatientyear source supplier inclusion risk business sustainable management sustainability auditing risk mitigation sustainability stribild green chemistry manufacturing supplier inclusion performance ghg emission distribution supply chain inclusion small andor esg risk financial risk environmental impact diverse supplier geographic risk supplier code green procurement vehemently oppose condemn biktarvy practice environment practice environment pursue inclusive procurement supplier inclusion share good practice western regional minority supplier development council group vision biopharmaceutical support growth welfare minority community championing industry leader supplier inclusiveness use minorityowne business northern california nevada hawaii inclusion diversity fuel innovation gilead help forge strong risk management performance productive supplychain partnership vision biopharmaceutical industry leader supplier inclusion commit create foster inclusive gilead longstanding member drug insurance group dig highperforming supply base embrace leverage unique talent small consortium global company represent pharmaceutical biotech business andor business own woman minority lgbtq individual veteran diagnostic medical device industry exchange information idea servicedisable veteran promote risk insurance management establish follow inclusion target gilead launch threeyear responsiblesource strategic plan enhance supplier risk management performance assessment report spend million small business audit procurement integration effort establish supplier inclusion champion select business function integrate supplier inclusion procurement process procedure initial assessment supplier report expand audit system integration help build capacity grow relationship inclusive supplier initial assessment implement expand responsible source believe supplier selfassessment selfassessment fully integrate partner follow organization supplier tool send audit include buydesk code psci secondary critical supplier supplier onboarde business critical supplier srm sustainable diversity alliance science alliance identify small andor diverse business gilead industry peer partner integral plan supplier code conduct establish minimum requirement supplier diversity labor practice human right environmental supplier diversity pharmaceutical forum forum member dedicate health safety environmental impact management system aim supplier annual spend agree supplier code drive business result innovation agility performance conduct mentor develop small diverse supplier practice environment practice environment end supplier represent continually monitor supply chain adequate capacity diversification potential risk adherence gilead policy govern regulation close billion annual spend agree foreign corrupt practice act fcpa traffic victim protection act supplier code conduct tvpa applicable labor environmental regulatory policy refer ethic code conduct section website information supplier sustainability evaluate address risk ethical violation country involve supply chain help improve sustainability performance supplychain partner join pharmaceutical supply chain initiative psci goal encounter actual potential violation company policy govern preferred supplier align psci guideline sustainability target regulation recommend corrective action flag supplier followup place regularly review plan initially work select supplier evaluation certain violation use force labor human trafficking establish greenhouse gas ghg reduction target plan expand environmental negligence lead gilead terminate agreement process include large share supplier future supply organization remove supply chain auditing procedure safety ethic transparency gilead environmental health safety ehs audit program drug substance conduct onsite audits ehs visit unique gilead adhere strict product safety labeling marketing datum security anti supplier program establish counterfeit guideline product undergo rigorous development testing site visit audits determine extent chemical raw material clinical trial use label marketing practice pursuant governing believe policy regulation gilead receive official warning fine manufacturer supplier finish apis meet gilead ehs standard penalty relate marketing labeling practice business practice include capture volatile organic compound chemical solid waste sustainable disposal solvent recycling compliance local international standard protect personal datum use combination inhouse technology party security service system comply data protection regulation assessment risk mitigation auditing procedure continually european union general datum protection directive substantiate evolve ensure product consistently produce control complaint concern breach customer privacy loss customer datum accord quality standard gmp work closely supplier identify practical improvement area share good practice reduce anticounterfeite team consist brand protection legal security supplychain eliminate risk quality packaging professional protect patient safety measure help detect stop deter report illicit sale counterfeit divert medicine practice environment practice environment greenhouse gas prevention sustainability year measure scope ghg emission result business climate change activity worldwide scope emission associate business travel report gilead greenhouse gas reporting boundary include site gilead maintain operational control jan dec environment bureau veritas north america inc complete limited assurance international organization standardization iso standard greenhouse gas assertion global health gilead publish verify worldwide greenhouse gas inventory datum available climate change intensify greenhouse gas ghg emission threaten ghg reduction initiative health population environment worldwide population impact effect climate change underserved community baseline year measure ghg reduction year track gilead provide medical care lifethreatening medical condition scope emission site operational control hiv viral hepatitis visceral leishmaniasis gilead establish target reduce impact climate change underserved atrisk population important absolute scope marketbase ghg implication global health include increase transmission believe disease compound health risk young elderly great danger emission compare immunocompromise global citizen provide care gilead business baseline sustainable stand patient atrisk population environment ambitious ghg strategy meet goal line paris agreement central aim keep global temperature rise degree celsius century develop multiyear plan include procure renewable energy highimpact location apply energy efficiency technology measure improve performance facility practice environment practice environment gilead reduce absolute scope marketbase ghg emission scope ghg emission gilead worldwide operation metric ton carbon dioxide equivalent mt coe equivalent reduction baseline emission reporting unit mt coe scope scope marketbase scope locationbase reporting unit mt coe scope business air travel baseline goal scope scope marketbase scope locationbase rsecpoopret ing b uunsiitnse sksg aciro traev epler square foot scope ghg emission intensity scope marketbase scope locationbase reporting unit kg coe square foot scope current year reduction target pace scope marketbase scope locationbase believe business sustainable practice environment practice environment alternative transportation energy use gilead proactively support employee find alternative lowimpact mean gilead energy management strategy support lean effective highquality transportation variety program initiative include therapeutic development optimize process facility operation realize major reduction energy footprint investing provide local regional commuter bus service campus renewable energy implement energyefficiency measure adopt support carpool program subsidy incentive advanced energy process locate office near public transit start procure renewable electricity headquarters instal electric vehicle charge station campus foster city california achievement represent major milestone encouraging bicycle transportation installation shower meet greenhouse gas emission reduction goal foster city join facility partner bicycle service provider campus cork ireland cambridge uk site procure instal green energy foster city transportation metric worldwide energy consumption year track total energy use nonrenewable source renewable energy generate onsite system purchase local utility track energy use intensity evaluate efficiency building portfolio grow believe business compare baseline year total energy use increase sustainable organic growth organization include activity newly build site commuter transport gilead metric ton coe emission employee bus day reduce employee vehicle commuter bus program practice environment practice environment worldwide energy consumption well water management energy energy use begin united nations call international decade action consumption intensity energy source mwh kwhsqft water sustainable development action identify access clean drinking water sanitation hygiene critical societal need prolong total energy consumption renewable source drought california region world gilead total energy consumption nonrenewable source operation increase focus water conservation total combine energy consumption energy efficiency december gileads foster city campus complete comprehensive upgrade smart building energy efficiency key driver reduce worldwide energy consumption facility personnel continuously monitor build energy use weatherbase irrigation controller identify trend pinpoint opportunity energy conservation commitment renewable energy strongly support mission gain well understand worldwide impact water supply reduce worldwide environmental footprint expand water use report boundary headquarters campus foster city california include site operational control andor pay gilead implement energy efficiency project worldwide water directly gilead consume ml water municipal source achieve estimate total energy saving mwh electricity supply gilead facility locate foster believe city california cork ireland source renewable energy worldwide water consumption business sustainable onsite rooftop solar photovoltaic system cambridge capable water source megaliter generate kwh renewable energy day indoor use irrigation firelife safety total water consumption practice environment practice environment increase recycling effort worldwide waste disposal commit reduce waste generate manufacturing product nonhazardous waste disposal metric ton construct new building operate exist facility worldwide reduce landfill impact local landfill continuously monitor operation identify opportunity organic reduce reuse recycle waste reduce total waste send recyclable landfill foster city headquarters incineration late expand waste reporting boundary foster city campus total include worldwide site operational control andor pay waste disposal directly generate metric ton nonhazardous waste metric ton hazardous waste serve baseline year future hazardous waste disposal metric ton comparison incineration hazardous nonhazardous waste stream pick facility energy recovery transport local processing facility thirdparty vendor comply ewaste recyclable local regulation onsite storage neutralization solvent recovery collective impact metal recovery recovery reuse waste reduction recycling require team effort gilead support deepwell injection believe worldwide staff divert metric ton nonhazardous waste landfill business local landfill total sustainable september gilead foster city host shre ewaste event collect metric ton paper electronic waste recycle construction waste new pilot plant foster city divert metric ton debris local landfill appendix appendix appendix governing principle gilead company drive science dedicate improve patient care quality life gilead adhere high legal ethical standard business conduct gilead sciences inc lead biopharmaceutical company discover protect patient safety company employee develop commercialize innovative medicine area unmet medical need strive transform promise science technology therapie gilead board director serve stockholder oversee management power cure disease revolutionize standard care gilead portfolio business board leadership team employee gilead product pipeline investigational drug include treatment hiv liver responsible uphold corporate value integrity inclusion teamwork disease cancer inflammatory respiratory disease excellence accountability addition gilead employee comply code ethic antibribery anticorruption policy headquarter foster city california gilead employ fulltime employee business conduct corporate policy engage temporaryagency worker country continent board committee audit committee compensation committee nominate corporate governance committee scientific committee board guideline committee charter find investor website list rule require majority member public company board director qualify independent committee compose individual employ engaged agency worker thirdparty temporary agency compensate independent board member march daniel oday appointment perform work gilead predefine timeframe john martin resignation member independent appendix appendix code stand approach csr gileads governance body employee comply code year gilead discover develop expand access ethic antibribery anticorruption abac policy corporate bestinclass therapeutic treat lifethreatening illness ensure policy available gnet company intranet accessible continue execute mission future reduce social manager employee abac training provide environmental impact result business activity build employee contractor audit committee subset board corporate social responsibility csr program focus patient society director regional business partner distributor locate asia north planet business america south america objective reduce impact climate change foster well community success gilead code ethic depend employee compliance attract retain topti employee mitigate supplychain risk prepare relevant law rule regulation associate employment include law future regulatory change prohibit insider trading assemble csr committee shepherd vision build assess adequacy key corporate policy annually help ensure accountability drive positive social environmental change consistent current regulation good governance practice company supply chain leader human resource legal operation public affair responsible reviewing making decision csr product distribute world gilead affiliate relate strategy stakeholder engagement report risk mitigation act gilead behalf require comply applicable anticorruption relevant activity gilead subsidiary annually csr committee law law include united states foreign corrupt practice act fcpa provide report nominate corporate governance committee uk bribery act applicable law gilead offer training material gilead board director employee relevant individual organization communicate gilead prohibition corrupt unethical activity csr management stakeholder gilead perform internal external audits monitor compliance regulatory engagement materiality company policy audits perform roughly country financial fcpa compliance gilead use companywide management approach continuously monitor internal external material impact purpose reduce potential actual finding corruption healthcare compliance negative impact associate company operation business leader direct violation government body oversight topic area responsible managing impact internal appendix appendix external stakeholder evaluate material topic effectiveness gileads management center approach year identify strength corruption compliance state federal international law pertain area improvement bribery healthcare fraud abuse political drug safety recall adverse event provide relevant information effort accountability year evaluate csr anticounterfeiting counterfeit management approach stakeholder provide access product world include effort rank engagement process material impact access pricing ensure fair pricing maximize effectiveness charitable effort aim reduce disparity provide access give companywide csr program advance medical education support local community stakeholder engagement materiality effort eliminate accident manage occupational employee health exercise occur health safety risk ensure employee come harm gilead score safety work employee wellness effort promote employee wellness development internal stakeholders development engagement employee benefit wellbee recruiting engagement retention internal stakeholder represent inclusion effort promote inclusion diversity th place corporate communication corporate diversity cpazicklin index corporate contribution access operation climate change reduce greenhouse gas emission associate company emerge market pharmaceutical energy operation product energy efficiently political disclosure development manufacture global ethical source ensure supplier uphold appropriate standard accountability analyze commercial commercial process ethical supply chain corporate responsibility issue transparency corporate optimization environmental health manufacturing manage quality production capacity inventory manufacture political spend large safety facility human resource supplychain supply chain management legal tax investor relation publicly hold company design chemical product process reduce eliminate regulatory affair engage discuss green chemistry ranking earn topti generation hazardous substance sustainabilityrelate topic trendsetter mark responsible effort ensure marketing conduct ethically complie market local law regulation sp waste hazardous nonhazardous waste recycling water effort manage reduce water use operation year review appendix appendix un un reporting disclosurea description reference sdg gc boundary year review gri general disclosure gri content index external stakeholder gri content index gilead employee austria belgium brazil collective bargaining agreement spain percent worldwide workforce subject collective bargaining agreement un report disclosurea description reference ungc gilead external stakeholder include stakeholder group follow sdg boundary category gri general disclosure identify select stakeholder organization appendix gilead p appendix csr management stakeholder engagement p business leader company select follow material topic approach stakeholder engagement materiality activity brand product service science innovation science drive p csr program base extent gilead internal external influence key topic concern raise location headquarters relative impact peer evaluation diligence entity include consolidated appendix gilead p lfioncaantcioianl ostfa otpeemreantitosn p purpose report od bwoe uf ni nn edi rn sag hr iier pe p drt lc eo gn le fn ot r man topic g coil pa od r tc ioie nn ces inc publicly trade delaware mliastr koeft ms saetervrieadl topic aa af mnpr dip ec ea rmin c ada ati ex ai ra n ic las istru yos utr taa hnl aaa mg ee eum rr icoe apn et smtaidkdelheo eldaesrt e nnogratghe ment p banks global insurer ngo purpose look p csr rating regulator scale organization total square footage corporate facility report restatement information p year review corrected index aopnp pendi xof athbeo ut gile yaeda r review p worldwide academic institutional institution win ofo rkrm era st ion employee appendix gilead p investor change report analyst investor rulemaker medium supply chain poruarc tpicuerps os een avibroonumt tehnist r reepsoprot nsible delivery system pp risk watchdog report period assessor worldwide stockholder industry significant change organization practice environment responsible delivery system p association idtsa steu popf lmy cohsat irne cent report healthcare partner p rr ee pc oa ru tt inio gn yry c lp er inciple approach ap np ne un ad l ix approach csr p provider customer peer e cx ote ntr tl pin oit inia tt fv oe r q uestion ko ou rr p bu zr ko e v ia cb eo pu rt e sh idis e nr te p po ur bt lic affairs p insurance peer community business report csrgileadcom provider partner membership association science innovation partnership p supplier claim report accordance purpose report p patient gri standard statement senior decisionmaker purpose ceo letter p communities generic drug gri content index gri content index p manufacturers value principle standard norm appendix governing principle p disclosure refereenxctee grnria l ass sutraanndcaerd reporting period opfr jaacnti ce e ton vdierocn not g urneleesnsh thoeu dsies cgloassu rpe ries vmeanrktieodn w ith b c p b disclosure reference gri standard c report period cover jan dec include worldwide site gilead maintain operational control andor pay utility directly executivelevel responsibility economic appendix approach csr p environmental social topic appendix csr management stakeholder engagement p aall disclosure refleisret nocfe gtarkie holde sr tgarnoduaprdss reportinagn pde mrioadte orfia jlaitny dec disclosure mark b c bdisclosure reference gri standard creporte period cover jan dec dinclude worldwide site gilead maintain operational control andor pay utility directly aall disclosure reference gri standard report period jan dec disclosure mark b c bdisclosure reference gri standard creporte period cover jan dec dinclude worldwide site gilead maintain operational control andor pay utility directly year review gri content index disclosurea description reference un ungc reporting year review sdg boundary gri general disclosure organization appendix gilead p un un reporting disclosurea description reference sdg gc boundary activity brand product service science innovation science drive p gri general disclosure location headquarters appendix gilead p location operation gilead employee austria belgium brazil collective bargaining agreement spain percent worldwide workforce subject ownership legal form gilead sciences inc publicly trade delaware collective bargaining agreement corporation africa asia australia europe middle east north market serve year review america south america identify select stakeholder appendix csr management stakeholder engagement p purpose look p approach stakeholder engagement materiality scale organization un un reporting appendix gilead p disclosurea dkeey tcorpipictsi oannd concern raise reference sdg gc boundary wn ofo rkrm era st ion employee appendix gilead p gri general de fiisnn cat li onti cse uis ar li e n ssc alu td eme e nin st consolidated p purpose report define report content topic supply chain practice environment responsible delivery system p boundary gilead employee austria belgium brazil worldwide collective bargaining agreement spain percent worldwide workforce subject significant c hange ythee oargra niinza tirone anvdi ew list material topic taop cpoelnledcitxiv ec sbra rmgaainnaingge magernete msteanktesh ionl der en gagement p supply chain practice enpviropnmeennt rdespioxnsible delivery system p materiaalityp pendix precautiona ry princip ley oer aapprr oianch r evieawpp endix approach csr p identify select inyg estaakre hionld err evietwhe total square footage corporate facility report c losurea ed xe tes rc nr ai lp ni io tin ive r oe uf pr ue rn pc ose e report su dn g u gn c pa pg e r op uo nr dt rg ar pe pst ra ot ae cm tn ot ss af k ein hf oo lr dm ea r eio nn g agement ao onpn ndp p p e n ad eox orf f ct ath hls ie etr n yge eea amr r ien nn r rte e sv vit iea ewk hh aosld beere enn cgoargreemcteendt p worldwide ggrri c goenenralt diesclnosutre si ndex gri contkeey ntoptic iannd dconecexrn raise membership association science innovation partnership p change report disclosurea description ralel fgeilreeandc eem ployee austria belgium brazil su dn g ungc r op uo nr dt rg disclosurea e fdinn eati snti cce irs ai pli n stc tioalu tnd e med e nin st consolidated roeurf epruerpnocsee report su dn g ungc ppp ge r op uo nr dt rg sctoaltleemcteivnet bfraormga sineinnigo ra dgereceismioennmtsa ker ospuar ipnu rp poeserc ecneto fl wetoterlrd wide workforce subject p reporting period purpose report gri general disclosure collective bargaining agreement g r general ddisecflionsinugre rse port content topic boundary organization appendix gilead p organization appendix gilead p date recent report value principle standard norm appendix governing principle p appendix csr management stakeholder engagement aidcetinvtiitfiyeisng b aranndd sse lpercotidnugc ststa aknedh oseldrevircse science innovation science drive p laicstti voift imesat berraianl dtosp picrso duct service asncdie nmcaet er iianlnitoy vation science drive pp year review report cycle annual appendix csr management stakeholder engagement laopcpartoioanch tfo h estaadkqeuhaorltdeerrs engagement materiality p location headquarters g ri c l u gr ee n ea r al dl oe e ldk e f iio ix n snne w ccv aty tni l sc nt oor eiu co ce sfi rt r si aiv n rtpi h lice ea nio stse p k sci tl fn e e aa l auot htv n n na epe od l mee l l c drr l ena ee eo nidt gs rn ni tp ac g ss en l h ro ofn rs ec ra ci pmb ol sr n l oi st spy oe lf c io ds r e tec nomic aa g cr oo np pp ie ul r dep pp rf p aee ee pmodn nn r ur ae dd rs pti ii n ecx xx ooi rc e sno aen e lb su c rr e u bmtp agp n unir c tl ao e gaa hs ecd h sa rt p eo eu n pc b ol rcr ttl ay kt era hd oe ldd e r e el na gw aa gr ee ent su dn g u g n c p pp pp g e r op uo nr dt rg rl oc r c geoeo l rwapcsn iinoat mt sa erta titt sr aoc e nn om h p fio e po arfn e ri dt ps not p f oe ro tfr lir eni nq ggifu ie n lnr fms oat rco mt cn oo rn dr e ag na cr ed win ig th h e oa g ck c oh osn nop ulre r r ep rp p pa aet pob dn ur dz al ra se pu ti ol cx ia ok ofs e sq nta th n ehu cb e c v eoa e mr cu se f ig op n u oir c tl ye e yt te ea hsagid ad sar e rnon pn e tf u r r pc bep eo olvu ivr rcipb tie le yol wi w cr r ha ae dff eaf dbirc es di el et ni le acs will r r ae r rep eco tr et de p p worldwide md boe auf ri knn edin tasg r iser ee srp vo er dt content topic af mri eca ri c aia n su os utr ta hl aa e eu rr ico ap e middle east north c mgh raa ir n kceg ote nss es enn r r v ie enp ddo er xt ing year revie oa agw f murr ri iec cpa riuo c rna apt aoeia nsne dt snau ods buet txa uh l tm h e iesu r rr ico eap p e r iddle east north pp gilead employee austria belgium brazil report period isclosure refscl ei c ros ealt nl le eo cc ef mi gfv tae rht ibe e r oi ra rg l g aoi n n spi tni z ac ag ns ia ag rnr e se nde n ht v e reportin ga aoo npp p uda cp eroi e r n mp iln ol eu ad crti pex op ior fve c sae jr e alc ib nter ya ln ro mt g oo kfn niw na inggo g e r tl od w ge drn eedt cee w eao k n r e tk hf io nr lc uee nr l e sen srg e ta h gs eue dbm ij ccn lott ure mark wit h b p c p c l osurea ddse cx aeat te esler cn ora fi fpl tathois eo ss tuno rr rea gcn aec nne izt aretipoon rt pror aeau ycr f et picr uee rs p n ocs eee n vlioroonkimnge natt gree n house gas prevention su dn g u gn c ppapge r op uo nr dt rg bdisclosure reference gri standard appendix gilead p appendix gilead p creporte period cover jan dec gri management approach c l u des worldwidi wi rn de eo f eso srni tkrt atem eis tfreya sfi mto niorg e nw na tohn snid c f eg inlp ei fl ol ceo rtay midne g ame ia tia nnn k tad ei hno oethdld eoerpr se rationala chp n npoe p pp pn e ett ro n dla ioal ox x n fs f qda cth hub e eao rr r u pe mt fg aod nio l u aye ytt ea ga ei agl ed ai ret ri ie ino ens f n r rc tei eor v se vr ipc tie aeto wl kwyr e hi htn ae lf da b ec e ri el et ni ne c gs r r ge ep c mo tr e et de n p worldwide bi wn ex oof ppo urlokr nam er dntr aa iasn rt g yi io cn ny ocn lfe te hm e p mlo ay tee ias la tn od p io c ah ne dr aanpnpueanld ix gilead p p saupppprolya cchha tion stakeholder engagement panradc mticaetse ria elintyv ironment responsible delivery system p l l isclosure refc rt eteh suo rpe epn con pt om cral mteyc gpcn p oha roa ng iii ee nn nmt tf seo nr sq tu ape nps drt aoio ra dnc ssh ar nae dng da h r ad vi en g rth epe rtink cp ga eso r np prar gepac ratbe gii gocn iz lde ed eu mi aokx f ea jc n ce av tosn n ai mrv c n e mr p n mrn aa se tg edn e trte om dlert tn ee ypt cs u p bot lani cks eiab hfl feoa lid dr usee nrl li ev se sr th ey ds se cm los u mark w h b r cp p worldwide kcehya ntogpeisc sin rnedp ocortnincge rn raise worldwide b c rd eis pc ol ro ts inu gre p r ee rf ie de n cc oe vs e g rsr ji n n toa r dd e c worldwide ie frt isi nn eg psn ntu oi cep ri tc isp aia n l liyn n gs c c palc hu eth ad era iman dg e ne ts tt ho e h coe n sr og la idn aiz tea dti po ru ar c p tiu cerp e e n vb iro ou not eh nis r ep prt nsible delivery system pp p dinclude worldwidc ge itev sil rg isini lm ustuief tpasis ac p nofai loo dyfn nr art c ew roc hdphfh oait c nhrnth eig n gemgsi al ietnnoa aa dtgc hmceeoma oriendrgtnaaatni nncaeeipzd paw ortoiipotahenc r tahaht nieod n alop cruaornc pttirucorelp sao nsd eeon arv bpiraooiudnt uttehilniistti ser pdeiosrpretoc tnlysi binle delivery system pp purpose report gri economic performance pd bdr oe ae utf ci enn di oun aftg rmo ier ne osap r rr ept crc eo n nn c tt pe reln e pt oa r rn tad p po rp oic ch mp ap ye n ix approach csr p g dprr irei ec c cao tu n etticoe onn nat rin dpicer xivn acliupele g oern aepraptreoda ch ga oprp ui c n pod uni rtxe pn ot u einr lae opx op kr io na gc h tt c r p pp distribute external initiative aopupre pnudripxo csesr mboaunta tgheim ernetp osrtta keholder engagement p eexxtteerrnnaall ainsistiuartaivnecse p oraucr tpicuersp os een vaibroonumt tehnit grerepeonrth ouse gas prevention pp worldwide lriespt oorft minagt ceyricalle opic aanndn umaal teriality p define benefit plan obligation work gilead compensation financial p retirement plan benefit membership association science innovation partnership p memberships association science innovation partnership p contact point question korab zuka vice president public affairs report tcshre tgoitlaela sdqcuoamre footage corporate facility report gri anticorruption srteastteamteemnet nfrtosm fs iennfoiorrm daeticoisni onmaker oonu rp pur poof stehe c eo l eyettaerr review correct p statement senior decisionmaker purpose ceo letter p p year review worldwide claim report accordance operation assess risk relate purpose report p gri standard aall disclosure refceorernrucpe tgiorni standard report period jan dec disclosure mark b c bdisclosure reference gri standard vc gah rla iu n ceg ose n ps te ri ninn c r iei npp dloe ers xt nstga ndard norm gp rp e cn od ni tx e u inr dg eo xv erne principle pp c ar nae clp duo idr st cei ln g sw oree rsr ldi ro d fie dc rcv eo ea n v sl cmeu ietre em gss j ru f inp n irr c wn c th sip c tnl ahe n gdn idso rldt e td sar n da ae nic mn da r hd iag ns v eaa bian reeu dn pt ooo rpr tm ienrgs tpieornioadla cop pofp npje aternn nod ld aix xn tou h rtr oe pg daco eiodv cde uer tn wli teg ie ssp r duai inn nrlc eedi cs p tsbll ye tyh ei n isclosure mark b c p p worldwide purpose report p b disclosure referencaen tgircio rrup stitoannd paordlsicie procedure report period c report period cover jan dec include worldwide site gilead maintain operational control andor pay utility directly e eex nxet vec irru ont naiv ml ea esl nes tvu aer la l nr nec dsep cs iaib l tl oit py co sr economic ap pra pc eti nc de x e un rv air po pn rm oae cn ht tg cee sn rh ouse gas prevention p p c ae ecx noe tvn ic oif rui nortm sni v mtee ad e kl ne ein tv nace li ld nen dstp oon cfs ic aibo l ir tlr oitu pyp ctoi sor ne caonndo mic appendix approach csr p disclosure referednacete g orif mos ts traencdeanrdt sr eanpdo hrta report period mof ajyan dec disclosure mark b c b disclosure reference gri standard gri energy c report period cover jan dec appendix csr management stakeholder engagement p appendix csr management stakeholder engagement p c lu es worldwide sl riit ese pt oofo rf r ts iw nta ghki c ceh yh cgo li elle aedr mgaroinutapinse operational control aaannnddno umr pala tiedr uiatilliittiye directly eli ns et ro gf cta ok ne sh uo mld pe tir g nr wou itp hs apnrda cmticaetesr ia leitnyv ironment worldwide energy c p organization consumption b dl il cd li os sc ulo resu rr ee fs e rr ee nfc cero epe snn gc ra te rc tg p ro ii n f tr nq dtua aen rsd dta si ordnss arnedg ahradvien ga rtehpeo rtink cg p rr earb gio iz ld eu aok dfa j c av oni mc e presid teo ndte pcu blic affai rusn disclosure mark b c energy consumption outside gilead currently track energy consumption creporte period cover jan dec organization outside organization dinclude worldwide site gilead maintain operational control andor pay utility directly future claim report accordance b c rd el cl p l cd uol dros esc inu slo gr wes pu er e r lf dis e wrr dee nf dcg ge c er er r ssi ien tg rs cc est oe sr j n gn fi n er ra n wr h ns c h ea x gs n dt ia la en r ad da e r c md ia nn ad nh ea dv e p er ap ior nti lo gg c rup ie n r cp ti ro ou od nr lp tao eo nf ns dje ta nra pb eao x iu u ih l er se e dpc io r ert c tl n u n disclosure mark b p pc b c rd n el cl p lcd uoli droc es c inu slo gr wes pu er e r lf dis e wrr dee nf dcee c enr e ses en r tg rc g ese sry j g fi ai nr rt e w n h c h gs n dt ia la en r ad da e r c md ia nn ad nh ea dv e p er ap ior nti lg p c c rp oae n ncr tsit ruoi ocd le aos p n f dij ae onnn r v pi ar dn um ie l int tot e sw e doc ir rl ed cw tl yi ie n e n ue nr gley disclosure mark wit h b c p p worldwide c reduction energy consumption practice environment energy efficiency external assurance practice environment greenhouse gas prevention p gilead currently track reduction energy reduction energy requirement requirement associate manufacturing product service product future gri water b dl il cd li os sc ulo resu rr ee fs e rr ee nfe cr ee sn gce r g r ta ndta rd da rds reporting period jan dec disclosure mark b c b c water consumption practice environment well water management p worldwide creporte period cover jan dec dinclude worldwide site gilead maintain operational control andor pay utility directly aall disclosure reference gri standard report period jan dec disclosure mark b c bdisclosure reference gri standard creporte period cover jan dec dinclude worldwide site gilead maintain operational control andor pay utility directly year review un un reporting disclosurea description reference sdg gc boundary gri management approach explanation material topic boundary management approach appendix csr management stakeholder component engagement materiality p worldwide appendix appendix evaluation management approach gri economic performance direct econ omic value geenearart eidn review year review purpose look p distribute worldwide define benefit plan obligation work gilead compensation financial p disclosurea dre etir se cm rie pn tt op nla ns rbe en feef ri ets n ce un un reporting disclosurea description reference un un reporting sdg gc boundary sdg gc boundary ggrrii maanntiacgoermruepntti oanp proach gri emission explanation material topic operation assess risk relate c direct scope ghg emission boundary corruption management approach appendix csr management stakeholder ictso mcommupnoicnaetniotsn training aen pg pa eg ne dm ixe n tt h en cd da et wer eia slit ty nd p p ww oo rr dd ww ii dd ee c indirect scope ghg emissions p anticorruption policy procedure evaluation management approach c indirect scope ghg emission practice environment ghg reduction worldwide confirm incident corruption initiative gri economica pcetirofnosrm taaknecne c ghg emission intensity gri enedrgirye ct economic value generate purpose look p distribute c energy consumption practice environment worldwide energy p worldwide c reduction ghg emissions p odregfainneizda btieonne fit plan obligation cwoonrksuinmgp attio gni lead compensation financial p retirement plan benefit gilead currently track energy consumption outside gilead currently track energy consumption emission ozonedeplete substance od ozonedeplete substance organization outside organization future gri anticorruption future gri effluent c eo conp ree rr urga pyt ti ioi onn ntse nassistye sse risk relate p cr oa nc st uic mes p io e nn vironment worldwide energy p worldwide c waste type disposal method p practices environment increase recycling c creodmumctuionnic oatfi oenn earngdy tcroaninsiunmg patbioonu practice environment energy efficiency effort p worldwide anticorruption policy procedure appendix code stand p worldwide c transport hazardous waste c ar pcreo otdn idoufi uncr cm sti ste aks nei ni dnnc sie ene vnr cg ey r fe cqourirruepmtieonnt sa nodf g rei qle ua d mo ee ns sn sc ou crr iae tn et dly wtr ia thck r ae nd uu fc cio tun rs nin g e itn se rgy gri supplier environmental assessment product future new supplier screen practice environment risk management gri energy environmental criterion performance p gri water worldwide energy consumption practice environment worldwide energy c organization consumption p negative environmental impact supply chain practice environment auditing procedure b c water consumption practice environment well water management p worldwide action take gilead currently track energy consumption p energy consumption outside outside organization organization gri employment future c energy intensity practice environment worldwide energy new employee hire employee turnover work gilead people number p consumption p worldwide p b c rd el il p cd oli rocs c inulo gre pu r er ee rf e rr dee nf cre c oer e sd en ug rc sce r j ig ao nnr f e n ea rs ng dt ta oan rc dd doa en r cd n p h n v e report p rp ae cri icd e f j en n v ir n e nto enec e r g e f fi c ie u nn cl ye ss disclosure mark w th b c b noe tn pe rfi ots v ip dr eo dv td oe td e mto p f ou rl al rt yim oe r pe rp tl imye ee es th pa lot ya ere e work gilead reward p worldwide dinclude worldwide site gilead maintain operational control andor pay utility directly recognize retain employee reduction energy requirement gilead currently track reduction energy parental leave p requirement associate manufacturing product service product future disclosure reference gri standard report period jan dec disclosure mark b c disclosure reference gri standard report period jan dec disclosure mark b c b disclosure reference gri standard b disclosure reference gri standard cg rreip orte w peartieodr cover jan dec c report period cover jan dec include worldwide site gilead maintain operational control andor pay utility directly include worldwide site gilead maintain operational control andor pay utility directly b c water consumption practice environment well water management p worldwide aall disclosure reference gri standard report period jan dec disclosure mark b c b c rd eis pc ol ro ts inu gre p r ee rf ie de n cc oe vs e g rsr ji n n toa r dd e c b dl il cd li os sc ulo resu rr ee fs e rr ee nfe cr ee sn gce r g r ta ndta rd da rds reporting period jan dec disclosure mark b c dinclude worldwide site gilead maintain operational control andor pay utility directly creporte period cover jan dec dinclude worldwide site gilead maintain operational control andor pay utility directly year review un un reporting disclosurea description reference sdg gc boundary gri occupational health safety worker representation formal joint managementworker health safety committee work gilead building culture p worldwide workplace safety type injury rate injury b occupational disease lose day absenteeism number workrelate fatality gri training education work gilead professional personal average hour training year employee p development worldwide percentage employee receive regular work gilead compensation p performance career development review financial benefit gri diversity equal opportunity work gilead people diversity governance body employee p number ratio basic salary remuneration woman work gilead compensation p man financial benefit gri local community appendix appendix operation local community engagement community impact give p worldwide impact assessment development program community gri supply social assessment year review year review new supplier screen social p criterion practice environment risk management worldwide performance disclosurea description reference su dn g u gn c r op uo nr dt rg disclosurea dn ace etg isoa cnt ri sv pe ta ts kio oec nni l impact supply chain reference su dn g u gn c ppage r op uo nr dt rg year review gri occupational health safety ggrrii coucsctuopmaetiro hneaal hlthe aalnthd asnadfe stya fety worker representation formal joint worker representation formal joint managementworker health safety committee work gilead building culture p worldwide c losurea da prsa eosn dsea ucsgs crme itp ae tnine odtn nto ef w rt vho ie cr k ehe e cra hl tt eeh ga oltnh rid ea ssn adf estayf eimtyp caocmtsm oift tee p trwrr ea oa nfrc ekst ii prnc eae gnrs e c n te c ge le v air n bm ue iln dt n ga afe cty u l te ut rh eic os f nd su dn g u gn c pa pp g e r bw oo op ur rl lod ndw wr dti iaid dn eg workplace safety workplace safety type injury rate injury type injury rate injury b occupational disease lose day gri b marketinogc caunpda ltiaobnealli ndgis ease lose day absenteeism number workrelate fatality absenteeism number workrelate fatality requirement product service information gri training education gri traininga anndd l aebdeulcinagti aall disclosure rienfceirdeencnet g orf inn oonnccoo smmtpapnlliidaaannrccdees acnodn chearvnei nag r epproordtiuncgt paenrdio jan dec disclosure mark b c average hour training year employee dw eo vr eki ln og p mat e g ntil ead professional personal p b c r eis p c ol ro ts inu gre p r ee rf ie de n ecvc roeve vrs iaec g grese r j hi u r ft ta rn tiona r idnd gs e c p er ear employee dp tw rr eaoa vnrc ek stii lpnc oaeg prs mea not e cg ne ytin l evairdon mpreonfte ssaiofentayl aenthdi cpse arsnodn al pp worldwide dinclude worldwide site gilead maintain operational control andor pay utility directly worldwide worldwide incident nnoonnccoommpplliiaannccee concern market p pe er rc foe rn mta ag ne c eo f e nm p calo ry ee ee r ere vc ee loiv pin mg e r ne tg ru el va ier ws fw ino ark ni cn ig la bt eg nil ee fa d compensation p p pcoe emr rc fome rn mutna aigc nea c eoio f ne nsm p calo ry ee ee r ere vc ee loiv pin mg e r ne tg ru el va ier ws fw ino ark ni cn ig la bt eg nil ee fa d compensation p gri customer privacy gri diversity equal opportunity gri diversity equal opportunity diversity governance body employee nw uo mrk bin eg rs gilead people p ds cuu iv sb e ts ort eyt r oa pft g d vo vc ceo yrm n ap nl n da c ln e ot sbs oc edo si n e oc fe car un n si dn og e mb er pe rl oa dyc aeh te ae ss np tw rr uaoa mnrck st bii pnc eaeg rrss ea not cge yin levairdon moeunr tp esoapfelety b ye tthhiec pp wuosrld ownidlye r ana dti ef n b asic salary remuneration woman fw ino ark ni cn ig la bt eg nil ee fa d compensation p r ana dti ef n b asic salary remuneration woman fw ino ark ni cn ig la bt eg nil ee fa d compensation p gri local community gri local community imp pe ar tt ao sn ss e w ssit mh elo nc tsa l c dm dm evu en li oty p man eg na g pe rom ge rn c co om mm mu un ni ty ie sm pact give p worldwide imp pe ar tt ao sn ss e w ssit mh elo nc tsa l c dm dm evu en li oty p man eg na g pe rom ge rn c co om mm mu un ni ty ie sm pact give p worldwide gri supply social assessment gri supply social assessment new supplier screen social new supplier screen social p p criteria criteria practice environment risk management practice environment risk management worldwide worldwide performance performance negative social impact supply chain n ace tg ioa nti sv e ta ko ec ni al impact supply chain p action take p gri customer health safety gri customer health safety disclosure reference gri standard report period jan dec disclosure mark b c disclosure reference gri standard report period jan dec disclosure mark b c b disclosure reference gri standard b disclosure reference gri standard c report period cover jan dec c report period coavsesrse jsasnm e not ttoh dee hce alt h safety impact practice environment safety ethic include worldwidaes ssietesss mfore wnht iochf tghilee ahde maaltihnt aainnded oapfeertayt iiomnapla ccotnst roofl andor ppairda ucttiilcitieess di reenctvlyir ion nment safety ethic p worldwide include worldwidep sriotedsu focrt wanhidch geirlveiacde caaintetaginoerdie osp erational control andor paitdr auntilsitpieasr deinreccyt ly p worldwide product service category transparency aall disclosure reference gri standard report period jan dec disclosure mark b c b dl il cd li os sc ulo resu rr ee fs e rr ee nfe cr ee sn gce r g r ta ndta rd da rds reporting period jan de c disclosure mark b c bdisclosure reference gri standard creporte period cover jan dec creporting period cover jan dec dinclude worldwide site gilead maintain operational control andor pay utility directly dinclude worldwide site gilead maintain operational control andor pay utility directly aall disclosure reference gri standard report period jan dec disclosure mark b c bdisclosure reference gri standard creporte period cover jan dec dinclude worldwide site gilead maintain operational control andor pay utility directly